Anika Therapeutics | ANIK - نسبة السعر إلى الأرباح





Pe تغيير تاريخ
Abbott 30.71 14.41 2025-12
Agios Pharmaceuticals 3.56 0.68 2025-09
Anika Therapeutics 47.54 27.2 2024-06
Halozyme Therapeutics 23.16 7.7 2025-12
Integra LifeSciences 6.58 0.5 2025-12
Intrexon 7.54 221.44 2021-12
J&J 23.62 0.86 2025-12
Ligand Pharmaceuticals 60.65 17.62 2025-09
Merit Medical Systems 39.12 6.7 2025-09
Rigel Pharmaceuticals 8.61 8.4 2025-03
Sanofi 11.99 1.58 2025-12
Smith & Nephew 17.63 4.2 2025-12
Stryker 32.13 2.69 2025-12
Surmodics 386.18 225.66 2021-12
Veracyte 45.3 5.4 2025-12
Xencor 29.92 3.22 2022-09
Zimmer Biomet Holdings 17.91 3.5 2025-12